Coenzyme Q10: Clinical Applications beyond Cardiovascular Diseases.
Lara TestaiAlma MartelliLorenzo FloriArrigo Francesco Giuseppe CiceroAlessandro CollettiPublished in: Nutrients (2021)
Coenzyme Q10 (CoQ10) is an essential cofactor in oxidative phosphorylation (OXPHOS), present in mitochondria and cell membranes in reduced and oxidized forms. Acting as an energy transfer molecule, it occurs in particularly high levels in the liver, heart, and kidneys. CoQ10 is also an anti-inflammatory and antioxidant agent able to prevent the damage induced by free radicals and the activation of inflammatory signaling pathways. In this context, several studies have shown the possible inverse correlation between the blood levels of CoQ10 and some disease conditions. Interestingly, beyond cardiovascular diseases, CoQ10 is involved also in neuronal and muscular degenerative diseases, in migraine and in cancer; therefore, the supplementation with CoQ10 could represent a viable option to prevent these and in some cases might be used as an adjuvant to conventional treatments. This review is aimed to summarize the clinical applications regarding the use of CoQ10 in migraine, neurodegenerative diseases (including Parkinson and Alzheimer diseases), cancer, or degenerative muscle disorders (such as multiple sclerosis and chronic fatigue syndrome), analyzing its effect on patients' health and quality of life.
Keyphrases
- cardiovascular disease
- multiple sclerosis
- anti inflammatory
- papillary thyroid
- oxidative stress
- energy transfer
- end stage renal disease
- signaling pathway
- ejection fraction
- public health
- newly diagnosed
- heart failure
- healthcare
- squamous cell
- early stage
- type diabetes
- chronic kidney disease
- single cell
- peritoneal dialysis
- prognostic factors
- stem cells
- cell death
- atrial fibrillation
- mesenchymal stem cells
- metabolic syndrome
- cell therapy
- sleep quality
- case report
- childhood cancer
- young adults
- health information
- bone marrow
- pi k akt
- risk assessment
- mild cognitive impairment
- cardiovascular risk factors
- patient reported outcomes
- coronary artery disease
- resistance training
- endoplasmic reticulum
- reactive oxygen species
- human health
- health promotion